Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share (SPRO)

CUSIP: 84833T103

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
55,705,828
Total 13F shares
7,704,769
Share change
-53,821
Total reported value
$109,789,119
Price per share
$14.25
Number of holders
34
Value change
-$578,036
Number of buys
16
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 84833T103?
CUSIP 84833T103 identifies SPRO - Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share (SPRO) as of Q1 2018

As of 31 Mar 2018, Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share (SPRO) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,704,769 shares. The largest 10 holders included Atlas Venture Associates IX, LLC, Alphabet Inc., BVF INC/IL, FMR LLC, RA CAPITAL MANAGEMENT, LLC, Rock Springs Capital Management LP, VHCP Management II, LLC, Artal Group S.A., AWM Investment Company, Inc., and JPMORGAN CHASE & CO. This page lists 34 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.